基于美国JCI体系的规范化管理在我院泌尿外科高危药品管理中的应用

Abstract
Figure/Table
References (21)
Related Citation (10)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application of standardized management based on Joint Commission certificated by American Medical Institutions (JCI) on high risk drugs management in Department of Urology of Changhai Hospital of Shanghai ("our hospital" for short). Methods Since July 2016, standardized management model based on American JCI system were applied into high-risk drug management in Department of Urology of our hospital. The management satuation of high-risk drugs in Department of Urology before implementation of the model (from January to June 2016) was compared with that after implementation (from July to December 2016). Results After implementation, high-risk drug classification, disease, contraindication, storage, allocation, audit knowledge by nurses were significantly higher than those before implementation, the differences were statistically significant (P < 0.05). After implementation, high risk drug classification storage, double check, independent storage, personal management, base management, list of spare drugs, effective management, warning signs pass rate were significantly higher than those before implementation, the differences were statistically significant (P < 0.05). Conclusion Standardized management based on American JCI system can improve nurses' awareness of safe medication, and strengthen the management of high-risk drugs.

Key words： Standardized management Urology Surgery High-risk drug management Application value

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	TANG Shouyan SHENG Xia▲

Cite this article:

TANG Shouyan SHENG Xia▲. Application of standardized management based on Joint Commission certificated by American Medical Institutions on high risk drugs management in Department of Urology of our hospital[J]. 中国医药导报, 2017, 14(17): 131-133,149.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2017/V14/I17/131

[1] 张丽，李秀丽，邵丽.JCI标准下手术室高危药品及化学危险品的流程改进与管理[J].全科护理，2016，14（9）：947-948.
[2] 郭媛媛.基于JCI标准探讨该院高危药品的安全管理模式[J].中国卫生产业，2015，12（6）：79-80.
[3] 唐安，刘玉，唐曙华，等.在JCI标准指导下麻醉科麻醉药品的安全管理探索[J].江苏卫生事业管理，2013，3（6）：63-65.
[4] 谭晓娜，徐晴姣，郭其.高危药品分级警示标识用于医院药品管理实践与体会[J].中国药业，2015，24（6）：44-45.
[5] Bates D W，Saria S，Ohno-Machado L，et al. Big data in health care： using analytics to identify and manage high-risk and high-cost patients [J]. Health Affairs，2014，33（7）：1123-1131.
[6] 张明雄，丁蕾，邹顺.结合JCI标准加强病区药品规范化管理的效果研究[J].中国药房，2014，25（41）：3881-3884.
[7] 谢婉花，陈怡禄，和凡.基于JCI标准的高危药品管理的实践[J].中华护理杂志，2014，49（10）：1222-1225.
[8] 任小平，尤玉敏，翟艳，等.医疗机构高危药品管理现状[J].海峡药学，2014，26（6）：17-19.
[9] HPS2-Thrive Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients [J]. N Engl J Med，2014，2014（371）：203-212.
[10] 马云坤.高危药品规范化管理建议[J].中国实用医药，2013，8（2）：251-252.
[11] 张冬纳，翟书会，马金锋，等.JCI标准下高危药品管理模式的探索与实践[J].中医药管理杂志，2012，20（11）：1101-1103.
[12] 刘世林，杨晓蓉，黄亮，等.结合JCI标准加强我院病区科室药品管理[J].中国药房，2012，23（29）：2724-2725.
[13] 常红霞，郭绍来，徐艳萍，等.结合JCI标准健全药品库房质量管理体系的实践[J].中国药物应用与监测，2013， 10（1）：45-47.
[14] 朱元元，周俊.JCI理念下的医院高危药品的管理[J].解放军医院管理杂志，2012，19（6）：509-510.
[15] 张红旭，杨庆，郭辉.JCI认证标准在医院高危药品管理中的应用[J].中国药物警戒，2016，13（8）：482-483.
[16] 陈敏，王小芬，平永美.基于JCI标准指导下的麻醉科麻醉药品安全管理[J].中医药管理杂志，2016，24（2）：77-78.
[17] 李梅丽，邵志宇.JCI标准下我院高危药品管理[J].海峡药学，2015，27（11）：280-281.
[18] 蒋芳.基于JCI标准下的化疗药品安全防护管理[J].护理研究，2014，28（17）：2145-2146.
[19] 龙荣，何周康，彭翠英.按JCI标准管理高危药品[J].儿科药学杂志，2014，20（2）：52-54.
[20] 梁芝萍，张苗苗.医院高危药品规范化管理探讨[J].东南国防医药，2015，17（6）：671-672.
[22] 韩成林，孙丽，王庆华.PDCA循环方法在我院高危药品管理中的应用[J].中国药房，2016，27（7）：929-931.
[21] 张莉，乔亚群，李娟，等.等级医院评审中参照JCI标准加强病区高危药品管理的实践[J].护理管理杂志，2015， 15（12）：901-903.